Phase II trial of Sorafenib combined with on-demand Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer stage C)
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms STAB
- 22 Jun 2017 Status changed from active, no longer recruiting to completed.
- 06 Jun 2017 Results assessing the safety and efficacy of combination therapy of sorafenib and on-demand transarterial chemoembolization for advanced stage hepatocellular carcinoma, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 17 Jun 2016 Status changed from recruiting to active, no longer recruiting.